Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Incontinence, prolapse & sacral neuromodulation · California | Incontinence, prolapse & sacral neuromodulation · Arizona | |
|---|---|---|
| Surgeons, 2024 | 73 | 38 |
| Medicare fee-for-service cases | 5,242 | 2,602 |
| Growth since 2019 (Medicare FFS) | +0.1%/yr | +2%/yr |
| Forecast cases (Medicare FFS) | 6,070 in 2030 | 2,760 in 2030 |
| Forecast growth | +2.5%/yr to 2030 | +1%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 1.6 | 3.5 |
| Medicare Advantage share | 56% | 54% |
| Out of hospital | 20% (+9 pts since 2019) | 38% (+26 pts since 2019) |
| Cases per surgeon | 72 | 68 |
| Top 10 surgeons' share | 39% | 58% |
| Surgeons growing | 16 | 8 |
| New since the base year | 9 | 4 |
| Likely to stop billing it | 21 by 2026 | 7 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $13K | $5,169 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.